Neutrophils in COVID-19.

COVID-19 SARS-CoV-2 clinical trials granulocytes neutrophils scRNA-seq viral infection

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 12 01 2021
accepted: 10 03 2021
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 20 4 2021
Statut: epublish

Résumé

Strong evidence has been accumulated since the beginning of the COVID-19 pandemic that neutrophils play an important role in the pathophysiology, particularly in those with severe disease courses. While originally considered to be a rather homogeneous cell type, recent attention to neutrophils has uncovered their fascinating transcriptional and functional diversity as well as their developmental trajectories. These new findings are important to better understand the many facets of neutrophil involvement not only in COVID-19 but also many other acute or chronic inflammatory diseases, both communicable and non-communicable. Here, we highlight the observed immune deviation of neutrophils in COVID-19 and summarize several promising therapeutic attempts to precisely target neutrophils and their reactivity in patients with COVID-19.

Identifiants

pubmed: 33841435
doi: 10.3389/fimmu.2021.652470
pmc: PMC8027077
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

652470

Informations de copyright

Copyright © 2021 Reusch, De Domenico, Bonaguro, Schulte-Schrepping, Baßler, Schultze and Aschenbrenner.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Lab Clin Med. 1994 Jun;123(6):874-81
pubmed: 8201266
Front Pharmacol. 2020 Oct 09;11:572009
pubmed: 33162887
Trends Immunol. 2018 Nov;39(11):890-899
pubmed: 30253910
Nat Med. 2009 Apr;15(4):384-91
pubmed: 19305412
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Eur Respir J. 2018 Aug 2;52(2):
pubmed: 29946009
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Cell Death Dis. 2020 Oct 27;11(10):921
pubmed: 33110074
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Science. 2014 Dec 5;346(6214):1234-8
pubmed: 25477463
J Thromb Haemost. 2021 Feb;19(2):574-581
pubmed: 33217134
Eur J Immunol. 2019 Mar;49(3):386-397
pubmed: 30443903
Circulation. 2021 Jan 19;143(3):230-243
pubmed: 33197204
Sci Immunol. 2017 Apr 28;2(10):
pubmed: 28626833
Immunol Rev. 2016 Sep;273(1):48-60
pubmed: 27558327
Trends Immunol. 2020 Nov;41(11):965-967
pubmed: 33023856
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Int J Mol Sci. 2020 Feb 11;21(4):
pubmed: 32053993
Nat Commun. 2019 Jun 3;10(1):2395
pubmed: 31160568
Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
Circulation. 2020 Jul 14;142(2):101-104
pubmed: 32369390
Semin Immunol. 2016 Dec;28(6):561-569
pubmed: 27866916
PLoS One. 2013 Aug 28;8(8):e72249
pubmed: 24015224
J Immunol. 2016 Mar 1;196(5):2283-92
pubmed: 26826241
Crit Care. 2015 Feb 25;19:57
pubmed: 25887201
Cell. 2013 May 23;153(5):1025-35
pubmed: 23706740
Genome Med. 2021 Jan 13;13(1):7
pubmed: 33441124
Mol Med. 2011 Mar-Apr;17(3-4):293-307
pubmed: 21046059
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Emerg Microbes Infect. 2015 May;4(5):e28
pubmed: 26060601
Immunity. 2020 Aug 18;53(2):319-334.e6
pubmed: 32814027
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Science. 2017 Dec 1;358(6367):1202-1206
pubmed: 29191910
Physiol Rev. 2020 Oct 1;100(4):1597-1598
pubmed: 32639219
Science. 2017 Oct 6;358(6359):111-116
pubmed: 28983053
Cell Res. 2021 Mar;31(3):272-290
pubmed: 33473155
Cell Mol Immunol. 2020 Sep;17(9):992-994
pubmed: 32620787
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
Trends Immunol. 2019 Jul;40(7):565-583
pubmed: 31160207
Nat Rev Cancer. 2020 Sep;20(9):485-503
pubmed: 32694624
J Biol Chem. 2004 Oct 15;279(42):44123-32
pubmed: 15302890
J Exp Med. 2005 Jan 3;201(1):105-15
pubmed: 15630139
Blood Adv. 2021 Mar 9;5(5):1164-1177
pubmed: 33635335
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32926098
Front Pharmacol. 2020 Jun 05;11:870
pubmed: 32581816
Crit Care. 2020 Dec 10;24(1):688
pubmed: 33302991
Respir Med. 2013 Apr;107(4):524-33
pubmed: 23433769
Nat Rev Immunol. 2019 Apr;19(4):255-265
pubmed: 30816340
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Lancet Rheumatol. 2020 Dec;2(12):e764-e773
pubmed: 33015643
Cell. 2020 Nov 25;183(5):1383-1401.e19
pubmed: 33159858
Nat Immunol. 2020 Feb;21(2):135-144
pubmed: 31932813
Int J Mol Sci. 2020 Oct 29;21(21):
pubmed: 33138181
Int J Stroke. 2021 Feb;16(2):137-149
pubmed: 33103610
Int J Mol Sci. 2018 Dec 17;19(12):
pubmed: 30563002
Nat Rev Immunol. 2020 Jul;20(7):389-391
pubmed: 32439870
Immunity. 2020 Aug 18;53(2):303-318.e5
pubmed: 32579887
J Clin Invest. 2008 Dec;118(12):4036-48
pubmed: 19033672
PLoS One. 2012;7(11):e48939
pubmed: 23152825
Blood. 2020 Sep 10;136(11):1317-1329
pubmed: 32573711
Immunity. 2003 Oct;19(4):583-93
pubmed: 14563322
Lancet Rheumatol. 2020 Jul;2(7):e393-e400
pubmed: 32835245
Crit Care Med. 2017 Apr;45(4):e426-e432
pubmed: 27635771
Cell Death Differ. 2020 Nov;27(11):3196-3207
pubmed: 32514047
Immunity. 2018 Feb 20;48(2):364-379.e8
pubmed: 29466759
J Immunol. 2017 Jan 15;198(2):757-766
pubmed: 27974456
AIDS. 2012 Jul 31;26(12):F31-7
pubmed: 22526518
Lancet Rheumatol. 2020 Oct;2(10):e586-e587
pubmed: 32838320
J Leukoc Biol. 2020 May;107(5):809-818
pubmed: 32170882
Immunity. 2019 Feb 19;50(2):390-402.e10
pubmed: 30709741
Nature. 2020 Dec;588(7836):146-150
pubmed: 32726800
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Cancer Discov. 2020 Aug;10(8):1210-1225
pubmed: 32300059
Front Cell Infect Microbiol. 2017 May 01;7:160
pubmed: 28507954
J Inflamm (Lond). 2020 Oct 29;17:33
pubmed: 33139969
Sci Transl Med. 2020 Nov 18;12(570):
pubmed: 33139519
EClinicalMedicine. 2020 Nov;28:100590
pubmed: 33173853
Crit Care. 2020 Jul 18;24(1):445
pubmed: 32682440
Cancer Res. 2009 Feb 15;69(4):1553-60
pubmed: 19201693
Am J Respir Crit Care Med. 2017 Aug 1;196(3):315-327
pubmed: 28146645
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Front Immunol. 2020 Jan 31;10:3108
pubmed: 32082301
Retrovirology. 2017 Aug 23;14(1):42
pubmed: 28835242
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32329756
Nature. 2021 Feb;590(7847):635-641
pubmed: 33429418
Cell. 2020 Nov 25;183(5):1282-1297.e18
pubmed: 33098771
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Cell. 2020 Sep 17;182(6):1401-1418.e18
pubmed: 32810439
Nat Immunol. 2020 Sep;21(9):1119-1133
pubmed: 32719519
Sci Rep. 2020 Nov 12;10(1):19630
pubmed: 33184506
Nat Rev Immunol. 2014 May;14(5):302-14
pubmed: 24751955
Physiol Rev. 2019 Apr 1;99(2):1223-1248
pubmed: 30758246
EBioMedicine. 2020 Aug;58:102925
pubmed: 32745993
Am J Respir Crit Care Med. 2015 May 1;191(9):1001-11
pubmed: 25695403
Sci Rep. 2020 Mar 9;10(1):4320
pubmed: 32152402
Front Immunol. 2020 Jul 09;11:1259
pubmed: 32733442
Acta Pharmacol Sin. 2020 Dec;41(12):1539-1546
pubmed: 33110240
Immunity. 2017 Jan 17;46(1):15-28
pubmed: 28099862
Semin Immunopathol. 2013 Jul;35(4):455-63
pubmed: 23553215
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Cells. 2020 Sep 29;9(10):
pubmed: 33003471
Nat Rev Drug Discov. 2020 Apr;19(4):253-275
pubmed: 31969717
Nat Rev Immunol. 2009 Sep;9(9):609-17
pubmed: 19704417

Auteurs

Nico Reusch (N)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Elena De Domenico (E)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for Genomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.

Lorenzo Bonaguro (L)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Jonas Schulte-Schrepping (J)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Kevin Baßler (K)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Joachim L Schultze (JL)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for Genomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.

Anna C Aschenbrenner (AC)

Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Genomics & Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for Genomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.
Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH